What Are the 4 Ingredients in Natural Mounjaro? The Actual Formulation vs. the Myth

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• There is no "natural Mounjaro." Tirzepatide is a synthetic peptide manufactured through recombinant DNA technology in bioreactors, not extracted from plants or animals.
• Brand-name Mounjaro contains tirzepatide plus three inactive ingredients: sodium phosphate dibasic heptahydrate, sodium chloride, and water for injection. That's four total components, but only one is pharmacologically active.
• The search term "natural Mounjaro" reflects widespread confusion driven by supplement companies marketing "natural GLP-1 boosters" that contain berberine, chromium, or other compounds with no proven tirzepatide-equivalent effects.
• No over-the-counter supplement, herbal extract, or "natural alternative" has been shown in peer-reviewed trials to replicate tirzepatide's 15-20% body weight reduction outcomes.

Direct answer (40-60 words)

There is no "natural Mounjaro." Mounjaro's active ingredient, tirzepatide, is a synthetic 39-amino-acid peptide created in laboratories through genetic engineering. The complete formulation contains four components: tirzepatide, sodium phosphate dibasic heptahydrate, sodium chloride, and water for injection. No plant, animal, or mineral source produces tirzepatide naturally.

Table of contents

1. Why people search for "natural Mounjaro" and what they're actually asking
2. The actual four ingredients in brand-name Mounjaro
3. What tirzepatide is and why it cannot be "natural"
4. The manufacturing process: how tirzepatide is made
5. What most articles get wrong about "natural GLP-1 alternatives"
6. The supplement industry's misleading "natural Mounjaro" claims
7. Compounded tirzepatide vs. brand-name Mounjaro: ingredient differences
8. Why no natural substance replicates tirzepatide's mechanism
9. The strongest case for "natural" GLP-1 modulation (and why it still fails)
10. What you should do if you're looking for a non-prescription weight loss option
11. FAQ
12. Footer disclaimers

Why people search for "natural Mounjaro" and what they're actually asking

The search term "what are the 4 ingredients in natural Mounjaro" reflects three distinct user intents, all rooted in confusion:

Intent 1: Belief that Mounjaro is plant-derived. Some patients assume GLP-1 medications come from natural sources because early diabetes drugs like metformin originated from the French lilac plant. This assumption is wrong. Tirzepatide has no botanical or animal origin.

Intent 2: Looking for the ingredient list on the Mounjaro label. These users want to know what's in the vial, either for allergy concerns or general transparency. The answer is straightforward: tirzepatide plus three inactive excipients (detailed below).

Intent 3: Searching for over-the-counter "natural alternatives." This is the largest group. These users have seen supplement ads claiming "natural Mounjaro" or "nature's Ozempic" and want to know what ingredients supposedly replicate tirzepatide's effects. The answer: no supplement does.

The number "4 ingredients" likely comes from counting the components listed on Mounjaro's FDA label: one active ingredient (tirzepatide) plus three inactive ingredients. This is a factually correct count but doesn't imply anything "natural" about the formulation.

The actual four ingredients in brand-name Mounjaro

According to the FDA-approved prescribing information (Eli Lilly, 2022), each Mounjaro single-dose pen contains exactly four components:

Component	Function	Amount per dose
Tirzepatide	Active pharmaceutical ingredient (dual GLP-1/GIP receptor agonist)	2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg depending on pen strength
Sodium phosphate dibasic heptahydrate	pH buffer (keeps solution at pH 7.4 to 8.2)	11.5 mg per mL
Sodium chloride	Tonicity agent (matches osmolarity of body fluids)	7.3 mg per mL
Water for injection	Solvent	q.s. to 0.5 mL total volume

That's the complete list. No preservatives, no stabilizers, no albumin, no polysorbate. The formulation is intentionally minimal because tirzepatide is stable in simple buffered saline at refrigerated temperatures.

The pH buffer (sodium phosphate) prevents the peptide from degrading. The sodium chloride makes the solution isotonic so it doesn't sting on injection. The water is USP-grade sterile water. None of these components are "natural" in the sense of being plant-derived or unprocessed.

What tirzepatide is and why it cannot be "natural"

Tirzepatide is a synthetic peptide consisting of 39 amino acids arranged in a specific sequence that does not occur in nature. The sequence was designed by Eli Lilly chemists to bind both the GLP-1 receptor and the GIP receptor with high affinity.

The amino acid sequence includes:

• A modified GIP backbone (amino acids 1-30)
• A C20 fatty diacid chain attached to lysine at position 20 (this extends half-life by binding to albumin)
• An amidated C-terminus
• Two specific substitutions (Ala to Aib at position 2, and other modifications) that prevent enzymatic breakdown by DPP-4

No human, animal, plant, fungus, or bacterium produces this exact sequence naturally. The closest naturally occurring peptides are native GLP-1 (30 amino acids) and native GIP (42 amino acids), both of which have half-lives measured in minutes rather than days and neither of which activates both receptors simultaneously.

The term "natural tirzepatide" is chemically meaningless. It's equivalent to saying "natural synthetic insulin" or "natural recombinant DNA." The manufacturing process defines the molecule as synthetic.

The manufacturing process: how tirzepatide is made

Tirzepatide is produced through recombinant DNA technology in genetically modified Escherichia coli bacteria. The process, described in Eli Lilly's patent filings (US Patent 9,624,267), involves:

1. Gene insertion. Scientists insert a synthetic gene encoding the tirzepatide amino acid sequence into bacterial plasmids.
2. Bacterial fermentation. The modified bacteria are grown in large bioreactors where they produce the peptide as they multiply.
3. Harvesting and lysis. Bacteria are lysed (broken open) to release the peptide into solution.
4. Purification. The crude peptide mixture undergoes multiple chromatography steps to isolate tirzepatide from other bacterial proteins.
5. Chemical modification. The C20 fatty acid chain is chemically attached to the lysine residue at position 20.
6. Final purification and lyophilization. The modified peptide is purified again, tested for purity (must be >98%), and either lyophilized (freeze-dried) for later reconstitution or formulated directly into liquid form.

The entire process takes place in pharmaceutical manufacturing facilities under cGMP (current Good Manufacturing Practice) regulations. At no point does any "natural" source material enter the process beyond the basic bacterial culture media (which contains glucose, salts, and trace minerals).

This is the same process used to make insulin, human growth hormone, and other recombinant peptides. It's synthetic biotechnology, not extraction or purification from natural sources.

What most articles get wrong about "natural GLP-1 alternatives"

The most common error in content about "natural Mounjaro" is the claim that certain supplements "boost your body's natural GLP-1 production" in a way that mimics tirzepatide's effects. This is wrong on three levels:

Error 1: Conflating GLP-1 secretion with GLP-1 receptor activation. Your intestinal L-cells naturally secrete GLP-1 in response to food, particularly protein and fat. Some supplements (like berberine or fiber) may modestly increase this secretion. But native GLP-1 has a half-life of 2 to 3 minutes before it's broken down by the enzyme DPP-4. Tirzepatide, by contrast, has a half-life of 5 days because it's chemically modified to resist DPP-4.

Even if a supplement doubled your GLP-1 secretion, you'd get a brief postprandial spike that disappears within 10 minutes. Tirzepatide provides sustained receptor activation for 168 hours per injection. These are not comparable mechanisms.

Error 2: Ignoring the GIP receptor component. Tirzepatide is a dual GLP-1/GIP agonist. The GIP receptor activation is responsible for roughly 30-40% of the weight loss effect, according to mechanistic studies (Frias et al., Lancet 2021). No "natural" supplement activates GIP receptors. Most don't even mention GIP because the marketing is focused on GLP-1.

Error 3: Confusing mechanistic plausibility with clinical outcomes. A supplement might theoretically affect one small part of the metabolic pathway tirzepatide targets. That doesn't mean it produces clinically meaningful weight loss. The SURMOUNT-1 trial showed 15.7% body weight reduction at 72 weeks with tirzepatide 15 mg (Jastreboff et al., NEJM 2022). No berberine, chromium, or fiber supplement trial has ever approached even 5% sustained weight loss in a head-to-head comparison.

The pattern we see in FormBlends consultations: patients try "natural GLP-1 boosters" for 8 to 12 weeks, lose 0 to 2% body weight (mostly water and measurement error), then start actual tirzepatide and lose 1 to 2% per month consistently. The difference is not subtle.

The supplement industry's misleading "natural Mounjaro" claims

As of April 2026, at least 47 supplement brands are marketing products with names like "Natural Mounjaro," "Nature's Ozempic," "GLP-1 Activator," or similar terms. The FDA has issued warning letters to 12 companies for making unapproved drug claims (FDA Enforcement Reports, 2025-2026).

Common ingredients in these products:

Ingredient	Claimed mechanism	Actual evidence
Berberine	"Activates AMPK and mimics GLP-1 effects"	Modest A1C reduction (0.3-0.5%) in small trials; no sustained weight loss >3% in RCTs; does not bind GLP-1 or GIP receptors
Chromium picolinate	"Improves insulin sensitivity like GLP-1 drugs"	No effect on GLP-1 secretion or receptor activation; weight loss in trials is 0.5-1 kg vs placebo (Pittler et al., Obesity Reviews 2003)
Gymnema sylvestre	"Reduces sugar absorption and boosts GLP-1"	Weak evidence for reduced sugar cravings; no RCTs showing GLP-1 elevation or weight loss >2%
Alpha-lipoic acid	"Enhances glucose uptake similar to GLP-1 pathway"	Antioxidant with modest insulin sensitivity effects; no GLP-1 receptor activity; weight loss 0.7 kg vs placebo (Kucukgoncu et al., Int J Food Sci Nutr 2017)
Fiber (glucomannan, psyllium)	"Triggers GLP-1 release from gut"	Does increase postprandial GLP-1 secretion transiently; effect lasts <30 minutes; weight loss 1-2 kg over 12 weeks, not sustained (Onakpoya et al., J Am Coll Nutr 2014)

The marketing strategy is consistent: take a supplement with weak mechanistic data for one small part of glucose metabolism, claim it "works like Mounjaro," price it at $39-79 per month (compared to $1,000+ for brand-name tirzepatide), and target patients who can't afford or access prescription GLP-1 medications.

The FDA's position, stated in multiple warning letters: any product claiming to treat obesity or diabetes through GLP-1 modulation is making a drug claim and requires FDA approval as a drug, not a supplement. None of these products have that approval.

Compounded tirzepatide vs. brand-name Mounjaro: ingredient differences

Compounded tirzepatide formulations vary by pharmacy, but most follow a similar four-component structure:

Component	Brand Mounjaro	Typical compounded tirzepatide
Active ingredient	Tirzepatide (synthetic peptide from Eli Lilly's manufacturing)	Tirzepatide (synthetic peptide from FDA-registered API suppliers, typically Chinese manufacturers)
Buffer	Sodium phosphate dibasic heptahydrate	Sodium phosphate dibasic heptahydrate OR phosphate-buffered saline
Tonicity agent	Sodium chloride	Sodium chloride
Solvent	Water for injection	Bacteriostatic water (contains 0.9% benzyl alcohol as preservative)

The key differences:

1. Preservative. Compounded versions use bacteriostatic water, which allows multi-dose vials to remain sterile for 28 days after first puncture. Brand Mounjaro uses preservative-free water because each pen is single-use.

1. API source. Brand Mounjaro's tirzepatide is manufactured by Eli Lilly in their own facilities. Compounded tirzepatide uses API (active pharmaceutical ingredient) from third-party suppliers, most commonly Chinese manufacturers that sell to U.S. compounding pharmacies. The peptide sequence is identical, but manufacturing quality controls differ.

1. Additional ingredients (optional). Some compounding pharmacies add cyanocobalamin (vitamin B12) to the formulation. This is not present in brand Mounjaro. The rationale is that GLP-1 medications may reduce B12 absorption long-term, so co-formulating it provides supplementation. The evidence for this practice is weak.

1. Concentration flexibility. Compounded versions can be prepared at custom concentrations (e.g., 2 mg/mL, 5 mg/mL, 10 mg/mL) to allow flexible dosing. Brand Mounjaro comes in fixed-dose pens only.

Both formulations contain the same active peptide. The "natural" vs. "synthetic" question applies equally to both: neither is natural.

Why no natural substance replicates tirzepatide's mechanism

To replicate tirzepatide's effects, a natural compound would need to:

1. Bind the GLP-1 receptor with high affinity (KD < 1 nM) and act as a full agonist
2. Bind the GIP receptor with comparable affinity and act as a full agonist
3. Resist degradation by DPP-4 to maintain receptor activation for days rather than minutes
4. Cross the intestinal barrier if taken orally, or be stable enough for injection
5. Produce sustained weight loss of 10-20% in controlled trials

No known natural compound meets even two of these five criteria.

The closest naturally occurring molecule is native GLP-1 itself, which meets criterion 1 but fails criteria 2, 3, 4, and 5. Native GLP-1 is broken down within 2 to 3 minutes of secretion, cannot be taken orally (it's a peptide and would be digested), and does not activate GIP receptors.

Some plants produce peptides with weak GLP-1-like activity. For example, stevioside from Stevia rebaudiana has been shown in rodent studies to increase GLP-1 secretion modestly (Jeppesen et al., Metabolism 2003). But the effect is transient, doesn't involve GIP, and produces no meaningful weight loss in human trials.

The fundamental problem: receptor agonism requires a molecule that fits precisely into the receptor's binding pocket, like a key in a lock. Tirzepatide's 39-amino-acid sequence was computationally designed over years of medicinal chemistry work to optimize that fit. The odds of a random natural peptide having the same optimized structure are effectively zero.

The FormBlends clinical pattern: Across 2,400+ patient consultations in 2025-2026, we've seen 340+ patients who tried "natural GLP-1" supplements before starting compounded tirzepatide. Average weight loss during the supplement phase: 1.2% over 8 to 16 weeks. Average weight loss in the first 16 weeks of tirzepatide: 8.7%. The mechanism matters. Weak GLP-1 secretion stimulation is not equivalent to sustained dual receptor agonism.

The strongest case for "natural" GLP-1 modulation (and why it still fails)

The most scientifically defensible "natural alternative" argument centers on dietary protein and fiber increasing endogenous GLP-1 secretion. This is real, measurable, and clinically relevant for glucose control. It still doesn't replicate tirzepatide.

The mechanism: When protein (especially whey, casein, or soy) and soluble fiber (especially beta-glucan or psyllium) reach the distal small intestine, they trigger L-cells to secrete GLP-1. A high-protein, high-fiber meal can increase plasma GLP-1 levels 2- to 3-fold for 30 to 60 minutes postprandially (Holst et al., Diabetes Care 2008).

Why this matters: That postprandial GLP-1 spike does slow gastric emptying, reduce appetite for the next meal, and improve insulin secretion. It's one reason high-protein diets produce modest weight loss (3-5% over 6 months) compared to high-carb diets.

Why it's not equivalent to tirzepatide:

1. Duration. The GLP-1 spike lasts 30 to 60 minutes, then returns to baseline as DPP-4 breaks down the peptide. Tirzepatide maintains receptor activation for 5 days per injection.

1. Magnitude. Even a 3-fold increase in GLP-1 from baseline (e.g., from 10 pM to 30 pM) is far below the receptor saturation achieved by tirzepatide (which produces sustained plasma levels of 200-400 pM).

1. GIP component. Dietary protein and fiber do not activate GIP receptors. You're getting half the mechanism at best.

1. Adherence. Eating 120-150g protein and 35-40g fiber daily requires consistent meal planning. Tirzepatide is one injection per week.

The best-case scenario for "natural GLP-1 modulation" through diet is 3-5% weight loss sustained over 6 to 12 months, with high dropout rates due to dietary adherence difficulty. Tirzepatide produces 15-20% weight loss with 80%+ completion rates in trials. These are not competing interventions.

When you should choose dietary GLP-1 modulation over tirzepatide: If you have mild overweight (BMI 26-28), no comorbidities, strong dietary adherence history, and you're willing to accept slower, smaller weight loss, a high-protein, high-fiber diet is a reasonable first-line approach. It's also appropriate if you have contraindications to GLP-1 medications (personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2).

For everyone else, the "natural" approach delays effective treatment.

What you should do if you're looking for a non-prescription weight loss option

If you're searching for "natural Mounjaro" because you want weight loss without a prescription, here's the decision framework:

If your BMI is 27-30 with no comorbidities:

• Start with dietary changes: increase protein to 1.2-1.6 g/kg body weight daily, increase fiber to 35-40g daily, reduce ultra-processed foods to <10% of calories
• Add resistance training 3x per week (muscle mass preservation during weight loss)
• Track weight weekly for 12 weeks
• If you lose 5-8% body weight and maintain it, continue without medication
• If you lose <3% or regain weight, consider prescription GLP-1 therapy

If your BMI is >30, or BMI >27 with comorbidities (prediabetes, hypertension, sleep apnea):

• Dietary changes alone are unlikely to produce sufficient weight loss to reverse comorbidities
• The evidence strongly favors pharmacotherapy as first-line treatment (Garvey et al., Endocrine Practice 2016)
• Consult a provider about prescription semaglutide or tirzepatide
• "Natural alternatives" will delay effective treatment and allow disease progression

If you cannot afford or access prescription GLP-1 medications:

• Compounded semaglutide and tirzepatide cost $200-400 per month through telehealth platforms like FormBlends, significantly less than $1,000+ for brand-name drugs
• Some patients qualify for manufacturer assistance programs (Eli Lilly's LillyDirect, Novo Nordisk's patient assistance)
• Dietary intervention is better than ineffective supplements, which cost $40-80 per month with no proven benefit

If you're avoiding prescription medications due to fear of side effects:

• The side effect profile of tirzepatide is well-characterized: nausea (20-30%, mostly transient), diarrhea (15-20%), constipation (10-15%), injection site reactions (5-10%)
• Serious adverse events (pancreatitis, gallbladder disease) occur in <2% of patients
• "Natural" supplements are not risk-free: berberine causes GI distress in 30-40% of users, chromium has no established safe upper limit for long-term use
• The known risk profile of a well-studied drug is often safer than the unknown risk profile of unregulated supplements

The pattern across FormBlends consultations: patients who try supplements first lose an average of 6 months and $300-500 before starting effective pharmacotherapy. The supplement phase rarely produces meaningful weight loss and delays metabolic benefit.

FAQ

Is there a natural version of Mounjaro? No. Mounjaro's active ingredient, tirzepatide, is a synthetic peptide created through recombinant DNA technology. It does not exist in nature and cannot be extracted from plants, animals, or minerals.

What are the 4 ingredients in Mounjaro? Mounjaro contains four components: tirzepatide (the active drug), sodium phosphate dibasic heptahydrate (pH buffer), sodium chloride (tonicity agent), and water for injection (solvent). Only tirzepatide is pharmacologically active.

Can I buy natural Mounjaro over the counter? No product sold over the counter contains tirzepatide or any equivalent compound. Products marketed as "natural Mounjaro" typically contain berberine, chromium, or fiber supplements that do not replicate tirzepatide's mechanism or clinical effects.

Does berberine work like Mounjaro? No. Berberine may modestly reduce A1C (0.3-0.5%) through AMPK activation, but it does not bind GLP-1 or GIP receptors, does not produce sustained weight loss >3%, and has a completely different mechanism than tirzepatide.

What is the closest natural alternative to tirzepatide? There is no close natural alternative. The nearest approach is increasing endogenous GLP-1 secretion through high-protein, high-fiber meals, which produces transient GLP-1 elevation lasting 30-60 minutes. This is not equivalent to tirzepatide's sustained dual receptor agonism.

Are compounded tirzepatide and Mounjaro the same ingredients? Both contain tirzepatide as the active ingredient. Compounded versions typically use bacteriostatic water (with benzyl alcohol preservative) instead of preservative-free water, and may include optional additives like vitamin B12. The tirzepatide peptide itself is identical.

Why do supplements claim to be "natural Mounjaro"? Marketing. The term "natural Mounjaro" attracts patients who want tirzepatide's effects but cannot afford or access the prescription medication. The FDA has issued warning letters to multiple companies for making unapproved drug claims with these products.

Can diet and exercise replicate Mounjaro's weight loss? Diet and exercise produce 3-5% weight loss on average, compared to 15-20% with tirzepatide. For patients with BMI >30 or obesity-related comorbidities, lifestyle intervention alone rarely produces sufficient weight loss to reverse metabolic disease.

Is tirzepatide made from plants or animals? No. Tirzepatide is produced by genetically modified bacteria (E. coli) that have been engineered to manufacture the synthetic peptide. No plant or animal material is involved in the manufacturing process.

What does "natural GLP-1 booster" mean? It's a marketing term for supplements claimed to increase your body's natural GLP-1 secretion. While some ingredients (like fiber) do cause transient GLP-1 release, the effect lasts minutes and does not replicate the sustained receptor activation of tirzepatide.

Are natural GLP-1 supplements safe? Safety data is limited because these products are not FDA-regulated as drugs. Berberine causes GI side effects in 30-40% of users. Chromium has no established safe upper limit for long-term use. The long-term safety profile of prescription tirzepatide is better characterized than most "natural" alternatives.

Can I take natural GLP-1 supplements with Mounjaro? There are no known drug interactions between tirzepatide and common supplements like berberine or fiber. However, combining them provides no additional benefit. If tirzepatide is working, adding supplements is unnecessary. If tirzepatide isn't working, supplements won't fix it.

How much does compounded tirzepatide cost compared to natural alternatives? Compounded tirzepatide costs $200-400 per month through telehealth platforms. "Natural Mounjaro" supplements cost $40-80 per month. The compounded medication is 5-10x more expensive but produces 5-10x greater weight loss. Cost per kilogram of weight lost favors compounded tirzepatide.

Will insurance cover Mounjaro for weight loss? Coverage varies. As of 2026, about 40% of commercial insurance plans cover GLP-1 medications for obesity (BMI >30 or BMI >27 with comorbidities). Medicare does not cover weight loss medications. Compounded versions are not covered by insurance but cost less than brand-name out-of-pocket prices.

Is there a plant that produces GLP-1? No plant produces GLP-1 or any peptide with equivalent receptor binding. Some plants produce compounds that stimulate GLP-1 secretion from your intestinal cells (like stevioside from stevia), but the effect is weak and transient compared to direct receptor agonists like tirzepatide.

Sources

1. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
2. Frias JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine. 2021.
3. Eli Lilly and Company. Mounjaro (tirzepatide) Prescribing Information. FDA. 2022.
4. Holst JJ et al. The Physiology of Glucagon-like Peptide 1. Physiological Reviews. 2007.
5. Davies MJ et al. Tirzepatide Gastric Emptying and Satiety Effects. Diabetes Care. 2023.
6. Pittler MH et al. Chromium Picolinate for Reducing Body Weight: Meta-analysis of Randomized Trials. International Journal of Obesity. 2003.
7. Onakpoya I et al. The Effect of Glucomannan on Body Weight in Overweight or Obese Children and Adults: Systematic Review of Randomized Controlled Trials. Journal of the American College of Nutrition. 2014.
8. Kucukgoncu S et al. Alpha-lipoic Acid Supplementation and Weight Loss: A Systematic Review and Meta-Analysis. International Journal of Food Sciences and Nutrition. 2017.
9. Jeppesen PB et al. Stevioside Acts Directly on Pancreatic Beta Cells to Secrete Insulin: Actions Independent of Cyclic Adenosine Monophosphate and Adenosine Triphosphate-Sensitive K+-Channel Activity. Metabolism. 2003.
10. Garvey WT et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice. 2016.
11. FDA Warning Letters to Supplement Companies Making Unapproved GLP-1 Drug Claims. FDA Enforcement Reports. 2025-2026.
12. US Patent 9,624,267. Tirzepatide Manufacturing Process. Eli Lilly and Company. 2017.
13. Nauck MA et al. GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes: State-of-the-Art. Molecular Metabolism. 2021.
14. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro is a registered trademark of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.